{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:57:35Z","timestamp":1791496655937,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["NS116489"],"award-info":[{"award-number":["NS116489"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"NIDA Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008562","name":"The University of Texas at Austin","doi-asserted-by":"publisher","award":["TRC4"],"award-info":[{"award-number":["TRC4"]}],"id":[{"id":"10.13039\/100008562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phrs.2025.107987","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:36:58Z","timestamp":1760884618000},"page":"107987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cannabidiol and Beta-Caryophyllene: Chronic inflammatory pain"],"prefix":"10.1016","volume":"222","author":[{"given":"Mohammed","family":"Alnoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-1136","authenticated-orcid":false,"given":"Mohammad S.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Nwose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sophia","family":"Malbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Benamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107987_bib1","unstructured":"IASP, IASP Announces Revised Definition of Pain, (2020)."},{"issue":"36","key":"10.1016\/j.phrs.2025.107987_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"8","key":"10.1016\/j.phrs.2025.107987_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain."},{"issue":"159","key":"10.1016\/j.phrs.2025.107987_bib4","first-page":"1","article-title":"Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02","volume":"13","author":"Schappert","year":"2006","journal-title":"Vital.. Health Stat."},{"key":"10.1016\/j.phrs.2025.107987_bib5","article-title":"Fifth edition","author":"Association","year":"2013","journal-title":"Diagn. Stat. Man. Ment. Disord."},{"issue":"12","key":"10.1016\/j.phrs.2025.107987_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11920-013-0421-0","article-title":"Pain and depression: an integrative review of neurobiological and psychological factors","volume":"15","author":"Goesling","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"issue":"6","key":"10.1016\/j.phrs.2025.107987_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jpain.2008.12.007","article-title":"Comorbid chronic pain and depression: who is at risk?","volume":"10","author":"Miller","year":"2009","journal-title":"J. Pain."},{"issue":"20","key":"10.1016\/j.phrs.2025.107987_bib8","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity: a literature review","volume":"163","author":"Bair","year":"2003","journal-title":"Arch. Intern Med."},{"issue":"4","key":"10.1016\/j.phrs.2025.107987_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7861\/clinmedicine.5-4-390","article-title":"Pain symptoms in depression: definition and clinical significance","volume":"5","author":"Katona","year":"2005","journal-title":"Clin. Med."},{"issue":"2","key":"10.1016\/j.phrs.2025.107987_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0033291709006035","article-title":"Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report","volume":"40","author":"Leuchter","year":"2010","journal-title":"Psychol. Med"},{"issue":"6","key":"10.1016\/j.phrs.2025.107987_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The economic burden of adults with major depressive disorder in the United States (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.phrs.2025.107987_bib12","first-page":"1","article-title":"Phytochemistry of cannabis sativa l","volume":"103","author":"ElSohly","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib13","article-title":"A novel phytocannabinoid isolated from cannabis sativa L. With an in vivo cannabimimetic activity higher than Delta(9)-tetrahydrocannabinol: delta(9)-Tetrahydrocannabiphorol","author":"Citti","year":"2019","journal-title":"Sci. Rep. 9"},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acs.jnatprod.9b00876","article-title":"Isolation of a high-affinity cannabinoid for the human CB1 receptor from a medicinal cannabis sativa variety: delta(9)-Tetrahydrocannabutol, the butyl homologue of delta(9)-Tetrahydrocannabinol","volume":"83","author":"Linciano","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"22","key":"10.1016\/j.phrs.2025.107987_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228870","article-title":"Cannabidiol for pain treatment: focus on pharmacology and mechanism of action","volume":"21","author":"Mlost","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2025.107987_bib16","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1097\/j.pain.0000000000001051","article-title":"Cannabis constituent synergy in a mouse neuropathic pain model","volume":"158","author":"Casey","year":"2017","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.phrs.2025.107987_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.phrs.2025.107987_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNR.0000000000001877","article-title":"Synergistic effect of cannabidiol and transcutaneous electrical nerve stimulation on neuropathic and inflammatory pain in mice","volume":"34","author":"Malta","year":"2023","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2025.107987_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114588","article-title":"Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male wistar rats","author":"Silva-Cardoso","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2025.107987_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108529","article-title":"Oral efficacy of Delta(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model","volume":"189","author":"Mitchell","year":"2021","journal-title":"Neuropharmacology"},{"issue":"1-3","key":"10.1016\/j.phrs.2025.107987_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2025.107987_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030853","article-title":"Pharmacokinetics of orally applied cannabinoids and medical marijuana extracts in mouse nervous tissue and plasma: relevance for pain treatment","volume":"15","author":"Dumbraveanu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2025.107987_bib24","article-title":"The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: a balanced placebo design trial","author":"De Vita","year":"2021","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/bcp.14973","article-title":"A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans","volume":"88","author":"Arout","year":"2022","journal-title":"Br. J. Clin. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2025.107987_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107987_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1039\/a703973e","article-title":"From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis","volume":"16","author":"Mechoulam","year":"1999","journal-title":"Nat. Prod. Rep."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107987_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/10284150600573660","article-title":"Flavor components of monoterpenes in citrus essential oils enhance the release of monoamines from rat brain slices","volume":"9","author":"Fukumoto","year":"2006","journal-title":"Nutr. Neurosci."},{"issue":"26","key":"10.1016\/j.phrs.2025.107987_bib30","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107987_bib31","unstructured":"FDA, CFR - Code of Federal Regulations Title 21, (2022)."},{"issue":"3","key":"10.1016\/j.phrs.2025.107987_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2007.04.059","article-title":"Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of cordia verbenacea","volume":"569","author":"Fernandes","year":"2007","journal-title":"Eur. J. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2025.107987_bib33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","article-title":"The cannabinoid CB(2) receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain","volume":"24","author":"Klauke","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107987_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/596312","article-title":"In vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic acid","author":"Fiorenzani","year":"2014","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.phrs.2025.107987_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2017.07.015","article-title":"Antiallodynic effect of beta-caryophyllene on paclitaxel-induced peripheral neuropathy in mice","volume":"125","author":"Segat","year":"2017","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.phrs.2025.107987_bib36","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/j.1532-2149.2012.00242.x","article-title":"Involvement of peripheral cannabinoid and opioid receptors in beta-caryophyllene-induced antinociception","volume":"17","author":"Katsuyama","year":"2013","journal-title":"Eur. J. Pain."},{"issue":"7","key":"10.1016\/j.phrs.2025.107987_bib37","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.3390\/molecules200711808","article-title":"The anticancer, antioxidant and antimicrobial properties of the sesquiterpene beta-Caryophyllene from the essential oil of aquilaria crassna","volume":"20","author":"Dahham","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.phrs.2025.107987_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0007114512001298","article-title":"The antioxidant effect of beta-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation","volume":"109","author":"Calleja","year":"2013","journal-title":"Br. J. Nutr."},{"issue":"12","key":"10.1016\/j.phrs.2025.107987_bib39","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1002\/jcb.27369","article-title":"beta-Caryophyllene, the major constituent of copaiba oil, reduces systemic inflammation and oxidative stress in arthritic rats","volume":"119","author":"Ames-Sibin","year":"2018","journal-title":"J. Cell Biochem"},{"issue":"9","key":"10.1016\/j.phrs.2025.107987_bib40","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/art.38724","article-title":"Contribution of transient receptor potential ankyrin 1 to chronic pain in aged mice with complete freund's adjuvant-induced arthritis","volume":"66","author":"Garrison","year":"2014","journal-title":"Arthritis Rheuma"},{"issue":"3","key":"10.1016\/j.phrs.2025.107987_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/can.2022.0006","article-title":"Contribution of g protein-coupled receptor 55 to periaqueductal Gray-Mediated antinociception in the inflammatory pain","volume":"7","author":"Blanton","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.phrs.2025.107987_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2010_108","article-title":"Animal models of depression: molecular perspectives","volume":"7","author":"Krishnan","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"97","key":"10.1016\/j.phrs.2025.107987_bib43","doi-asserted-by":"crossref","DOI":"10.3791\/52587-v","article-title":"The forced swim test as a model of depressive-like behavior","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.193474","article-title":"Revisiting the isobole and related quantitative methods for assessing drug synergism","volume":"342","author":"Tallarida","year":"2012","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/bja\/aet128","article-title":"Neuroinflammation and the generation of neuropathic pain","volume":"111","author":"Ellis","year":"2013","journal-title":"Br. J. Anaesth."},{"issue":"10","key":"10.1016\/j.phrs.2025.107987_bib46","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd1852","article-title":"Chemokines: integrators of pain and inflammation","volume":"4","author":"White","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.phrs.2025.107987_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.phrs.2025.107987_bib48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2025.107987_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000435931","article-title":"Neuroinflammatory mechanisms linking pain and depression","volume":"30","author":"Burke","year":"2015","journal-title":"Mod. Trends Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/pr.113.008144","article-title":"Neuroinflammation and comorbidity of pain and depression","volume":"66","author":"Walker","year":"2014","journal-title":"Pharm. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2025.107987_bib51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","article-title":"Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.phrs.2025.107987_bib52","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1523\/JNEUROSCI.2785-18.2018","article-title":"Microglia promote increased pain behavior through enhanced inflammation in the spinal cord during repeated social defeat stress","volume":"39","author":"Sawicki","year":"2019","journal-title":"J. Neurosci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:16:42Z","timestamp":1780805802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S1043661825004128"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107987","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol and Beta-Caryophyllene: Chronic inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107987"}}